Back
Lexaria Bioscience 10K Form
Sell
10
LEXX
Lexaria Bioscience
Last Price:
$1.21
Seasonality Move:
-8.36%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2021-04-14 | 10Q | LEXX/Lexaria Bioscience Quarterly |
2021-01-14 | 10Q | LEXX/Lexaria Bioscience Quarterly |
2020-10-15 | 10K | LEXX/Lexaria Bioscience Annual |
2020-06-29 | 10Q | LEXX/Lexaria Bioscience Quarterly |
2020-04-03 | 10Q | LEXX/Lexaria Bioscience Quarterly |
2020-01-09 | 10Q | LEXX/Lexaria Bioscience Quarterly |
Receive LEXX News And Ratings
See the #1 stock for the next 7 days that we like better than LEXX
LEXX Financial Statistics
Sales & Book Value
Annual Sales: | $464.3K |
---|---|
Cash Flow: | $-1.5M |
Price / Cash Flow: | 0 |
Annual Sales: | $0.41 |
Price / Book: | 2.85 |
Profitability
EPS (TTM): | -0.59000 |
---|---|
Net Income (TTM): | $-9.4M |
Gross Margin: | $459.5K |
Return on Equity: | -118.15% |
Return on Assets: | -107.34% |
Lexaria Bioscience Earnings Forecast
Key Lexaria Bioscience Financial Ratios
-
The Gross Profit Margin over the past 19 years for LEXX is 98.96%.
-
The Selling, General & Administrative Expenses for LEXX have been equal to 829.68% of Gross Profit Margin.
-
The Research & Development expenses have been 508.44% of Revenue.
-
The Net Earning history of LEXX is -1,248.24% of Total Revenues.
-
Per Share Earnings over the last 20 years have been positive in 11 years.
Lexaria Bioscience Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Pharmaceuticals |
Sector: | Health Care |
Current Symbol: | LEXX |
Website: | lexariabioscience.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 4.24 |
Quick Ratio: | 3.77 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
LEXX Technical Analysis vs Fundamental Analysis
Sell
10
Lexaria Bioscience (LEXX)
is a Sell
Is Lexaria Bioscience a Buy or a Sell?
-
Lexaria Bioscience stock is rated a SellThe current Lexaria Bioscience [LEXX] share price is $1.16. The Score for LEXX is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.